Enfusion, Inc. (ENFN)

NYSE: ENFN · Real-Time Price · USD
11.06
-0.03 (-0.27%)
Feb 12, 2025, 4:20 PM EST - Market closed
-0.27%
Market Cap 1.43B
Revenue (ttm) 195.16M
Net Income (ttm) 2.73M
Shares Out 128.97M
EPS (ttm) 0.03
PE Ratio 367.10
Forward PE 41.67
Dividend n/a
Ex-Dividend Date n/a
Volume 446,281
Open 11.03
Previous Close 11.09
Day's Range 11.03 - 11.12
52-Week Range 7.83 - 11.38
Beta 0.97
Analysts Hold
Price Target 10.38 (-6.15%)
Earnings Date Mar 11, 2025

About ENFN

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, an... [Read more]

Sector Technology
IPO Date Oct 21, 2021
Employees 1,102
Stock Exchange NYSE
Ticker Symbol ENFN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for ENFN stock is "Hold." The 12-month stock price forecast is $10.38, which is a decrease of -6.15% from the latest price.

Price Target
$10.38
(-6.15% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Inves...

18 hours ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Enfusion, Inc. (ENFN) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Invest...

3 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Invest...

7 days ago - Accesswire

Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Invest...

10 days ago - Accesswire

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Enfusion, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion,...

13 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Invest...

14 days ago - Accesswire

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion,...

15 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Invest...

17 days ago - Accesswire

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for pot...

21 days ago - Accesswire

Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the pr...

21 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Invest...

24 days ago - Accesswire

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion Inc For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 16, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion,...

27 days ago - Accesswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders

NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches...

Other symbols: ITCI
27 days ago - PRNewsWire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and EDBL on Behalf of Shareholders

NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breac...

Other symbols: EDBL
4 weeks ago - GlobeNewsWire

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Enfusion Inc For Securities Fraud

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. ("Enfusion" or "the Company") (NYSE:ENFN) for pot...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the pr...

4 weeks ago - Accesswire

ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (...

Other symbols: CWAN
4 weeks ago - Business Wire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Enfusion, Inc.

NEW YORK , Jan. 13, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Enfusion, Inc. (NYSE: ENFN) and its board of directors concerning the proposed acquisit...

Other symbols: CWAN
4 weeks ago - PRNewsWire

ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. with the Schall Law Firm.

4 weeks ago - Business Wire

Clearwater agrees to buy investment management platform Enfusion for $1.5B

Clearwater Analytics, a company developing accounting, compliance, and risk reporting tools for asset managers, said on Monday it has entered into a definitive agreement to acquire investment manageme...

Other symbols: CWAN
4 weeks ago - TechCrunch

Clearwater Analytics to acquire Enfusion in $1.5 bln deal

Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday.

Other symbols: CWAN
4 weeks ago - Reuters

Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

BOISE, Idaho & CHICAGO--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement fo...

Other symbols: CWAN
4 weeks ago - Business Wire

This Analyst With 85% Accuracy Rate Sees Around 10% Upside In Alphabet - Here Are 5 Stock Picks For 2024 From Wall Street's Most Accurate Analysts

U.S. stocks settled lower on Tuesday, with the Nasdaq Composite falling around 175 points during the session.

Other symbols: GOOGGOOGLLEN
5 weeks ago - Benzinga

Enfusion: Revenue Growth Should Start To Accelerate

I maintain a buy rating for ENFN, anticipating revenue growth to exceed 20% due to improving macro conditions and solid execution. The macro environment has shown signs of turnaround, with rate cuts a...

7 weeks ago - Seeking Alpha

Orbus Software Announces Strategic Growth Investment from FTV Capital and SilverTree Equity

NEW YORK & LONDON--(BUSINESS WIRE)-- #DigitalTransformation--Orbus Software announces strategic growth investment from FTV Capital and SilverTree Equity.

Other symbols: GLOB
2 months ago - Business Wire